MoneyWorks4Me

Krebs Biochemicals & Industries informs about compliances-certificate

09 Jan 2024 Evaluate
In Compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, Krebs Biochemicals & Industries has enclosed a copy of the Certificate received from KFIN Technologies, the Registrar and Share Transfer Agent of the Company, for the quarter ended December 31, 2023.

The above information is a part of company’s filings submitted to BSE.

Krebs Biochem.&Inds Share Price

52.12 -1.06 (-1.99%)
03-Sep-2026 14:54 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1917.05
Dr. Reddys Labs. 1159.25
Cipla 1395.10
Lupin 2141.80
Zydus Lifesciences 1138.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: